Brothers Juan José and Andrés Aguirre Salazar of Grupo Bruluart discuss recent developments in the group and the strategic approach behind Bruluart’s impressive growth, helping it to proudly stand as one of the foremost healthcare companies in Mexico.
Grupo Bruluart contains well-established pharmaceutical manufacturers, a distribution company, and one of the most important pharmacy chains in the country. What is the DNA of the group common to these three companies?
Our comprehensive portfolio of companies provides us with a better ability to respond and adapt to evolving market needs, which is one of Bruluart’s key specificities and most important competitive advantages.
